Figure 7From: Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostatPanobinostat increases CDH1 expression in MDA-MB-231 primary tumors. Control and panobinostat treated, formalin-fixed mammary fat pad sections from MDA-MB-231-tRFP injected CB17-SCID mice were stained for H & E (left column) or anti-human CDH1 (1:30; right column) followed by Alexa Fluor® 488 secondary antibody. Original magnification was 100× with scale bars at 200 microns. tRFP, turbo red fluorescent protein; SCID, severe combined immunodeficiency.Back to article page